FDA surveillance shows how rivaroxaban compares to warfarin
HematologyTimes,
RivaroxabanThe US Food and Drug Administration’s (FDA) Mini-Sentinel surveillance system has revealed no new safety concerns…
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System
Overview of attention for article published in Pharmacoepidemiology & Drug Safety, January 2018
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
High Attention Score compared to outputs of the same age and source (93rd percentile)
Readers on
- mendeley
- 45 Mendeley